ClinicalTrials.gg
Not yet recruitingNCT07780214EHBM-PCOSHSFSUpdated Sep 11, 2026

EHBM-Based Intervention for Polycystic Ovarain Syndrome Among High Female School Students

An interventional study of Expanded health belief model based behavioural intervention for polycystic ovarain syndrome in Polycystic Ovarian Syndrome, sponsored by Salwan Abed Laftah. Not yet recruiting at 1 site in Iraq. Open to female participants aged 16 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Salwan Abed Laftah · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
16 Years to 18 Years
Sex
Female
01

Study summary

This study aims to examine efficacy of The Expanded Health Belief model-based intervention in enhancing female high school students' adherence to polycystic ovary syndrome health-protective behaviors.

Read the detailed description

The study will involve female high school students and use a Randomized Controlled Trial (RCT) design. Participants will be randomly assigned to an intervention group receiving an educational/behavioral program based on the Expanded Health Belief Model, and a control group receiving usual or routine information.

The intervention will aim to improve students':

Knowledge and awareness about PCOS Perceived susceptibility and severity of PCOS Perceived benefits and barriers to preventive behaviors Self-efficacy and motivation Adherence to healthy behaviors, such as healthy eating, regular physical activity, weight management, and appropriate health-seeking behaviors The effectiveness of the intervention will be assessed by comparing changes in PCOS-related health-protective behaviors between the intervention and control groups.

02

Conditions studied

  • Polycystic Ovarian Syndrome

Keywords

  • Expanded Health Belief Model
  • Polycystic Ovarian Syndrome
  • Randomized Controlled Trial
03

In context

Polycystic Ovary Syndrome

956 studies on the registry are indexed under Polycystic Ovary Syndrome; 176 are open to participants now.

This study's planned enrollment of 144 is above the median of 70 across 697 interventional studies indexed under Polycystic Ovary Syndrome.

Browse Polycystic Ovary Syndrome studies →

Lead sponsor

This is the only study on the registry with Salwan Abed Laftah as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female high school students enrolled in the selected schools during the study period.
  • Be within the predefined age range specified in the research protocol (for example, 15-18 years).
  • Be able to read and understand the language used in the intervention and questionnaires.
  • Be willing to participate in the study.
  • Have no previously diagnosed PCOS.
  • Not be currently participating in another structured lifestyle or PCOS educational intervention.

Exclusion criteria

Exclusion Criteria:

  • Have a previously diagnosed PCOS.
  • Have a medical condition that prevents or significantly limits physical activity recommended in the intervention.
  • Have a cognitive, learning, or communication difficulty that prevents them from understanding the intervention or completing the questionnaire.
  • Are currently participating in another structured lifestyle, weight-management, or PCOS educational program.
  • Are receiving a treatment or intervention that could substantially influence the study outcomes.
  • Are absent from a predetermined proportion of intervention sessions (for example, more than 20%-25%).
  • Fail to complete the baseline assessment or required post-intervention assessment.
  • Withdraw their consent/assent at any stage of the study.
  • Become unavailable because of transfer to another school, prolonged absence, or other circumstances that prevent completion of the
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
144 participants (estimated)

Study arms

  • Experimental
    Experimental

    the experimental group consists of female high school students who are randomly assigned to receive the Expanded Health Belief Model (EHBM)-based intervention. The intervention is designed to improve their understanding of Polycystic Ovary Syndrome (PCOS) and encourage them to adopt and maintain health-protective behaviors. The experimental group would receive a structured educational/behavioral program addressing the major components of the EHBM, such as: Perceived susceptibility: Helping students understand their potential risk factors for PCOS. Perceived severity: Increasing awareness of the possible health consequences of PCOS. Perceived benefits: Explaining the benefits of healthy behaviors in preventing or reducing PCOS-related risks. Perceived barriers: Identifying and overcoming obstacles to healthy eating, physical activity, and other protective behaviors. Self-efficacy: Building students' confidence in their ability to practice healthy behaviors.

    Behavioral: Expanded health belief model based behavioural intervention for polycystic ovarain syndrome

  • No intervention
    Control group

    If by "non-interventional group" you mean the control group in your randomized controlled trial, it is the group that does not receive the Expanded Health Belief Model (EHBM)-based intervention. Control (Non-intervention) Group The control group consists of female high school students who are randomly assigned not to receive the specific EHBM-based educational intervention during the study period. They may continue to receive their usual school health education or routine information about general health, depending on the study protocol.

Interventions

  • BehavioralExpanded health belief model based behavioural intervention for polycystic ovarain syndrome

    This is a non-pharmacological, behavioral intervention designed to enhance adherence to polycystic ovary syndrome (PCOS) health-protective behaviors among female high school students. The intervention is based on the Expanded Health Belief Model and consists of structured educational and behavioral sessions addressing key determinants of preventive health behaviors. The intervention includes education about PCOS, increasing perceived susceptibility and severity, emphasizing the benefits of health-protective behaviors, identifying and reducing perceived barriers, enhancing self-efficacy, providing cues to action, and strengthening health motivation. Practical guidance on healthy dietary practices, regular physical activity, healthy weight management, and appropriate health-seeking behaviors is also provided to support participants in adopting and maintaining PCOS health-protective behaviors.

06

What researchers measure

Primary outcomes

  1. Adherence to Polycystic Ovary Syndrome Health-Protective Behaviors

    Number of female high school students who would adhere to Polycystic Ovary Syndrome Health-Protective Behaviors as measured by the Behavioral Intention Scale to Adhere to Polycystic Ovary Syndrome Health-Protective Behaviors. The data will be collected using a self-reported tool. The Behavioral Intention Scale to Adhere to Polycystic Ovary Syndrome Health-Protective Behaviors includes the Dietary Intention subscale which encompasses 3 items (it ranges between 3-15). The Physical Activity Intention Subscale which encompasses 2 items (it ranges between 2-10). The Medical Engagement and Monitoring Intentions which encompasses 3 items (it ranges between 3-15). All these items are measured on a 5-point Likert scale.

    Time frame: 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be publicly shared because the data contain potentially identifiable and sensitive information collected from adolescent participants.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07780214
Lead sponsor
Salwan Abed Laftah
Responsible party
Salwan Abed Laftah (Principal Investigator, University of Baghdad) — Sponsor-investigator
First posted
Aug 21, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Mar 10, 2027 (estimated)
Completion
Apr 10, 2027 (estimated)
Last update
Sep 11, 2026

Study contacts

Salwan Abed Laftah, PhD
Contact
solwan.abd1206a@conursing.uobaghdad.edu.iq
+9467816193527

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion